Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by MetLife Investment Management LLC
MetLife Investment Management LLC lessened its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 16.5% during the 4th quarter, Holdings Channel reports. The fund owned 25,636 shares of the biopharmaceutical company’s stock after selling 5,076 shares during the quarter. MetLife Investment Management LLC’s holdings in Sage Therapeutics were worth $139,000 at […]
MetLife Investment Management LLC lessened its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 16.5% during the 4th quarter, Holdings Channel reports. The fund owned 25,636 shares of the biopharmaceutical company’s stock after selling 5,076 shares during the quarter. MetLife Investment Management LLC’s holdings in Sage Therapeutics were worth $139,000 at […]
